With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most ...
With the approval of anti-amyloid monoclonal antibodies to treat early-stage Alzheimer’s disease (AD), the need for accurate and early diagnosis is crucial. Blood-based biomarkers offer a promising ...
AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) ...
Alzheimer’s disease remains a frustratingly difficult condition to manage for the millions of patients affected worldwide and their families. The cause of the disease is still not properly ...
(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX), and health care technology company Babson Diagnostics, announced Tuesday an expansion of fingertip blood collection and ...
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results